DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Biofil Chemicals & Pharmaceuticals Limited — Outcome of Board Meeting

NSE 3 hrs ago·11 Aug 2026, 12:54 pm

Company NSE

Biofil Chemicals & Pharmaceuticals Limited has informed the stock exchanges regarding its financial results for the period ending June 30, 2026. This submission marks a standard regulatory update where the company discloses its performance data to the market.

For investors, this information is crucial as it provides the most recent snapshot of the company's financial health. It allows shareholders to evaluate the firm's operational efficiency and track its progress against previous periods.

Investors should focus on key metrics such as revenue growth, net profit margins, and cash flow. Monitoring these figures will help in assessing the company's current trajectory and future potential.